Walleye Trading
MDGL icon

Walleye Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Walleye Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
700
+300
+75% +$154K ﹤0.01% 2832
2026
Q1 		$209K Buy
+400
New +$191K ﹤0.01% 3088
2025
Q4 		– Sell
-700
Closed -$321K – 4654
2025
Q3 		$321K Buy
+700
New +$261K ﹤0.01% 3056
2025
Q1 		– Sell
-20,400
Closed -$6.29M – 4456
2024
Q4 		$6.29M Buy
+20,400
New +$5.74M 0.01% 1015
2024
Q2 		– Sell
-1,300
Closed -$347K – 4662
2024
Q1 		$347K Sell
1,300
-12,400
-91% -$2.92M ﹤0.01% 3074
2023
Q4 		$3.17M Sell
13,700
-2,800
-17% -$490K 0.01% 1558
2023
Q3 		$2.41M Buy
16,500
+3,500
+27% +$659K 0.01% 1647
2023
Q2 		$3M Sell
13,000
-700
-5% -$190K 0.01% 1339
2023
Q1 		$3.32M Buy
13,700
+5,500
+67% +$1.5M 0.01% 1344
2022
Q4 		$2.38M Sell
8,200
-6,800
-45% -$665K 0.01% 1550
2022
Q3 		$975K Buy
15,000
+6,600
+79% +$459K ﹤0.01% 2271
2022
Q2 		$601K Buy
+8,400
New +$617K ﹤0.01% 2721
2020
Q4 		– Sell
-7,200
Closed -$855K – 4800
2020
Q3 		$855K Sell
7,200
-16,900
-70% -$1.83M ﹤0.01% 1783
2020
Q2 		$2.73M Buy
+24,100
New +$2.37M 0.02% 878
2020
Q1 		– Sell
-5,400
Closed -$492K – 4320
2019
Q4 		$492K Buy
+5,400
New +$524K ﹤0.01% 2422
2019
Q3 		– Sell
-11,500
Closed -$1.21M – 4259
2019
Q2 		$1.21M Buy
11,500
+3,600
+46% +$386K 0.01% 1438
2019
Q1 		$990K Buy
+7,900
New +$982K 0.01% 1669

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Walleye Trading's MDGL Position: Q2 2026 in Review

Walleye Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 490% in Q2 2026, buying an estimated $203K and bringing the position to 478 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

Walleye Trading first reported a position in MDGL in Q3 2015 and has held it in 10 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Walleye Trading held 478 shares of Madrigal Pharmaceuticals worth $257K as of Q2 2026.
  • Walleye Trading bought 397 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $203K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3010 holding.
  • Walleye Trading first reported a position in Madrigal Pharmaceuticals in Q3 2015 and has held it in 10 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.